MedPath

Duodenal Exclusion for the Treatment of Type 2 Diabetes

Not Applicable
Withdrawn
Conditions
Diabetes
Registration Number
NCT00534547
Lead Sponsor
Medtronic - MITG
Brief Summary

The purpose of this study is to investigate the role of an experimental surgery that may offer better short and long-term control of T2DM in select patients who have not achieved adequate blood sugar control with regular means.

Detailed Description

Not available

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Treatment success based on patients' glycemic control12 Months
Secondary Outcome Measures
NameTimeMethod
Physiologic Measurements, Comorbidity improvement, Improvement in QOL12 Months

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.